
Newloris Pharmaceuticals Private Limited
Founded in 2024 and headquartered in Telangana, India.
Founded in 2024 and headquartered in Telangana, India.
Newloris Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 December 2024 ( four months 0 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hrudaya Chanti and Gopal Vankadothu serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U47721TS2024PTC192485
192485
Private Limited Indian Non-Government Company
30 Dec 2024
-
-
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hrudaya Chanti ![]() | Director | 30-Dec-2024 | Current |
Gopal Vankadothu | Director | 30-Dec-2024 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Newloris Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Hrudaya Chanti is a mutual person
Hrudaya Chanti is a mutual person
Hrudaya Chanti is a mutual person
Hrudaya Chanti is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Newloris Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Newloris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newloris Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Hrudaya Kiran Chanti was appointed as a Director was appointed as a Director on 30 Dec 2024 & has been associated with this company since 4 months .
Gopal Naik Vankadothu was appointed as a Director was appointed as a Director on 30 Dec 2024 & has been associated with this company since 4 months .
Newloris Pharmaceuticals Private Limited was registered on 30 Dec 2024 with Roc Hyderabad & aged 4 months as per MCA records.
Newloris Pharmaceuticals Private Limited was incorporated on 30 Dec 2024.
The authorized share capital of Newloris Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Newloris Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Newloris Pharmaceuticals Private Limited is Flat No.301 Virgo Galaxy Sri Harsha Colony India, Rajendranagar, Telangana, 500086.
The corporate identification number (CIN) of Newloris Pharmaceuticals Private Limited is U47721TS2024PTC192485 and the company number is 192485 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.